In addition, the expression of Galectin-9 was also detected in multiple types of B cells, which may include normal and malignant cells, revealing the complex network between tumor cells and background cells, and further suggesting the significance of TIM3/Galectin-9 pathway in DLBCL. Here, LGALS9 is linked to diffuse large B-cell lymphoma.